We are live on ! Find out more
CLPT icon

ClearPoint Neuro

78 hedge funds and large institutions have $76.5M invested in ClearPoint Neuro in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more capital invested

Capital invested by funds: $38M → $76.5M (+$38.5M)

46% more call options, than puts

Call options by funds: $1.02M | Put options by funds: $695K

0% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 21

1% less ownership

Funds ownership: 25.73%24.73% (-1%)

9% less funds holding

Funds holding: 8678 (-8)

36% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 22

Holders
78
Holders Change
-8
Holders Change %
-9.3%
% of All Funds
1.12%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
21
Reduced
21
Closed
22
Calls
$1.02M
Puts
$695K
Net Calls
+$321K
Net Calls Change
+$262K
Name Holding Trade Value Shares
Change
Change in
Stake
BCM
26
Bridgeway Capital Management
Texas
$751K
Northern Trust
27
Northern Trust
Illinois
$616K -$1.22M -127,663 -70%
CSS
28
Cubist Systematic Strategies
Connecticut
$597K -$235K -24,531 -32%
NA
29
Navellier & Associates
Nevada
$561K
Renaissance Technologies
30
Renaissance Technologies
New York
$548K -$1.16M -120,800 -71%
PHS
31
Pekin Hardy Strauss
Illinois
$541K +$462K +48,250 New
Morgan Stanley
32
Morgan Stanley
New York
$525K -$415K -43,372 -48%
Ameriprise
33
Ameriprise
Minnesota
$432K +$369K +38,574 New
LPL Financial
34
LPL Financial
California
$432K -$9.58K -1,000 -3%
Squarepoint
35
Squarepoint
New York
$417K -$618K -64,572 -63%
SAM
36
Silvercrest Asset Management
New York
$400K
Connor, Clark & Lunn Investment Management (CC&L)
37
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$366K +$313K +32,661 New
UBS Group
38
UBS Group
Switzerland
$347K +$18.4K +1,921 +7%
Goldman Sachs
39
Goldman Sachs
New York
$327K -$933K -97,434 -77%
PAS
40
Point72 Asia (Singapore)
Singapore
$326K -$31.6K -3,304 -10%
JF
41
Jump Financial
Illinois
$273K +$70.6K +7,376 +44%
XT
42
XTX Topco
Cayman Islands
$223K +$66K +6,890 +53%
NA
43
NewEdge Advisors
Louisiana
$221K +$188K +19,683 New
T. Rowe Price Associates
44
T. Rowe Price Associates
Maryland
$199K
ACM
45
Aster Capital Management
United Arab Emirates
$196K +$168K +17,500 New
CC
46
Centiva Capital
New York
$195K -$209K -21,836 -56%
OC
47
Oppenheimer & Co
New York
$156K +$133K +13,929 New
Lazard Asset Management
48
Lazard Asset Management
New York
$153K +$131K +13,673 New
Bank of America
49
Bank of America
North Carolina
$152K -$37.1K -3,879 -22%
Verition Fund Management
50
Verition Fund Management
Connecticut
$123K +$105K +11,000 New

CLPT Hedge Fund Activity: Q3 2024 in Review

78 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q3 2024, worth a combined $76.5M — up 101% from $38M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of CLPT and 14 opened new positions — a net loss of 8 holders — while 21 trimmed existing stakes and 21 added.

The largest buyer was Marshall Wace, adding an estimated $2.09M. The largest seller was Millennium Management, cutting an estimated $1.82M.

  • 78 institutional investors held ClearPoint Neuro (CLPT) as of Q3 2024, down from 86 in Q2 2024.
  • Funds reported $76.5M of ClearPoint Neuro stock for Q3 2024, up 101% quarter-over-quarter.
  • 14 funds opened new ClearPoint Neuro positions in Q3 2024 and 22 closed out, a net change of -8 holders.
  • The largest ClearPoint Neuro buyer in Q3 2024 was Marshall Wace, an estimated $2.09M added.
  • The largest ClearPoint Neuro seller in Q3 2024 was Millennium Management, an estimated $1.82M sold.

Based on aggregated 13F filings for Q3 2024.